An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
NCT03924427
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
BMS-986165
Sponsor
Bristol-Myers Squibb